Tumor suppression by small molecule inhibitors of translation initiation
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
// Limo Chen 1,* , Bertal H Aktas 1,2,* , Yibo Wang 1 , Xiaoying He 1,3 , Rupam Sahoo 1 , Nancy Zhang 1 , Severine Denoyelle 1 , Eihab Kabha 1 , Hongwei Yang 1 , Revital Yefidoff Freedman 1 , Jeffrey G Supko 1,3 , Michael Chorev 1,2 , Gerhard Wagner 1 , and Jose A Halperin 1,2 1 Harvard Medical School 2 Brigham and Women’s Hospital 3 Massachusetts General Hospital * These authors are equal contributors Correspondence: Jose A. Halperin , email: // Keywords : Translation, eIF4F, eIF4E, ternary complex, eIF2 Received : August 09, 2012, Accepted : August 24, 2012, Published : August 25, 2012 Abstract Translation initiation factors are over-expressed and/or activated in many human cancers and may contribute to their genesis and/or progression. Removal of physiologic restraints on translation initiation causes malignant transformation. Conversely, restoration of physiological restrains on translation initiation reverts malignant phenotypes. Here, we extensively characterize the anti-cancer activity of two small molecule inhibitors of translation initiation: #1181, which targets the eIF2∙GTP∙Met-tRNA i ternary complex, and 4EGI-1, which targets the eIF4F complex. In vitro, both molecules inhibit translation initiation, abrogate preferentially translation of mRNAs coding for oncogenic proteins, and inhibit proliferation of human cancer cells. In vivo, both #1181 and 4EGI-1 strongly inhibit growth of human breast and melanoma cancer xenografts without any apparent macroscopic- or microscopic-toxicity. Mechanistically, #1181 phosphorylates eIF2α while 4EGI-1 disrupts eIF4G/eIF4E interaction in the tumors excised from mice treated with these agents. These data indicate that inhibition of translation initiation is a new paradigm in cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antitumor Activity and Mechanism of Action of the Cyclopenta[b]benzofuran, Silvestrol
Cencic, R., Carrier, M., Galicia-Vázquez, G., Bordeleau, M.-E., Sukarieh, R., Bourdeau, A., Brem, B., Teodoro, J. G., Greger, H., Tremblay, M. L., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005223 · Cited by 302
Cited by
Targeting the translation machinery in cancer
Bhat, M., Robichaud, N., Hulea, L., Sonenberg, N., Pelletier, J., & Topisirovic, I. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4505 · Cited by 799
Targeting the eIF4F Translation Initiation Complex: A Critical Nexus for Cancer Development
Pelletier, J., Graff, J., Ruggero, D., & Sonenberg, N. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2789 · Cited by 367
Pourdehnad, M., Truitt, M. L., Siddiqi, I. N., Ducker, G. S., Shokat, K. M., & Ruggero, D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310230110 · Cited by 286
Molecular Pathways: The eIF4F Translation Initiation Complex—New Opportunities for Cancer Treatment
Malka-Mahieu, H., Newman, M., Désaubry, L., Robert, C., & Vagner, S. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2362 · Cited by 105
The Role of Translation Control in Tumorigenesis and Its Therapeutic Implications
Xu, Y., & Ruggero, D. (2020) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030419-033420 · Cited by 67
Metadata
- Authors
- Chen, L., Aktas, B. H., Wang, Y., He, X., Sahoo, R., Zhang, N., Denoyelle, S., Kabha, E., Yang, H., Yefidoff Freedman, R., Supko, J. G., Chorev, M., Wagner, G., & Halperin, J. A.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2012-08-25
- Volume
- 3
- Issue
- 8
- Pages
- 869-881
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2157230060
- Cited by
- 104
- References
- 1
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tumor suppression by small molecule inhibitors of translation initiation. https://app.cochat.ai/papers/10.18632/oncotarget.598
- The paper
- Chen, L., Aktas, B. H., Wang, Y., He, X., Sahoo, R., Zhang, N., Denoyelle, S., Kabha, E., Yang, H., Yefidoff Freedman, R., Supko, J. G., Chorev, M., Wagner, G., & Halperin, J. A. (2012). Tumor suppression by small molecule inhibitors of translation initiation. Oncotarget. https://doi.org/10.18632/oncotarget.598
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.